|
Jan 10, 2022
|
Oxbryta® (voxelotor) Tablets for Oral Suspension, A New Dispersible Tablet Dosage Form, Now Available for Patients with Sickle Cell Disease in the United States
|
|
|
Jan 06, 2022
|
GBT Announces New Employment Inducement Grants
|
|
|
Jan 04, 2022
|
GBT to Present at the 40th Annual J.P. Morgan Healthcare Conference
|
|